The Star on MSN
Bronchitis vs pneumonia: Differences to know
Bronchitis and pneumonia are respiratory conditions that affect different parts of the lungs, although they can cause similar symptoms, including coughing and breathing difficulties.According to the ...
Nursing students and new nurses. Also for review and guidance for mid-career nurses. October 22, 2026 / Yuta ...
Hello, I'm Nurse komugi. ☺️🌾When you hear the words "brushing your teeth," what do you think it's for?To prevent cavities.To ...
The Healthy @Reader's Digest on MSN
The COVID booster and flu shot: Can you get both at once? Doctors’ advice for 2026-2027
Learn what virus specialists recommend as you head out for your seasonal vaccinations: "This is a small price to pay for protection," a leading infectious disease doctor says.
At a clinic in South Africa, researchers have identified airborne ESKAPE bacteria that survive most antibiotic medicines. The ...
A Russian plague lab worker died of "pneumonia of unknown origin," officials say, in response to initial reports that she was exposed to the deadly bacteria during a lab accident.
Longenpest kan ontstaan wanneer bacteriën de longen bereiken of wordt verspreid via besmette ademhalingsdruppels.
At a clinic in South Africa, researchers have identified airborne ESKAPE bacteria which survive most antibiotic medicines.
The lab worker died on October 2 after being hospitalised with severe pneumonia. She worked at the Irkutsk Anti-Plague Research Institute in Siberia, a facility that specialises in plague and other ...
No official cause of her pneumonia has been confirmed, and Russian health officials say that none of the deceased individual's close contacts tested positive for the plague. Pneumonic plague is a rare ...
24don MSN
A Plague Is Not The Same As Covid: Why The Suspected Russian Pneumonic Plague Should Not Cause Panic
Pneumonic plague is a serious and potentially rapidly fatal bacterial infection, but it is not the same disease as Covid-19. It is caused by Yersinia pestis, can spread through respiratory particles ...
BV100 is currently being studied in two clinical trials: the pivotal Phase 3 global registration trial, RIV-TARGET, which announced first patient first visit in April 2026, and the open-label Phase 2b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results